For instance, a study investigating the role of LDHA and LDHB subunits of lactate dehydrogenase (LDH) and lactate metabolism in glioblastoma tumor growth and invasion has shown that lactate is an important metabolic factor in tumor growth and invasiveness, and that Stiripentol, an antiepileptic drug that inhibits LDHA and LDHB activity, efficiently reduces glioblastoma’s development and invasion [77], demonstrating potential as a new therapeutic or adjuvant agent. This evidence concerns the gene LDHB and glioblastoma.